77 related articles for article (PubMed ID: 7847397)
21. [Screening of patients at risk for hepatitis C virus infection in general medicine].
Altman C; Lesiour A; Dunbavand A; Meyer L; de la Selle P; Buffet C
Gastroenterol Clin Biol; 1999 Mar; 23(3):359-62. PubMed ID: 10384340
[TBL] [Abstract][Full Text] [Related]
22. Infectious hazards of immune globulin.
Barton LL
J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
[No Abstract] [Full Text] [Related]
23. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
Sachithanandan S; Fielding JF
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
[TBL] [Abstract][Full Text] [Related]
24. Comparison of risk factors for hepatitis B and C in patients visiting a gastroenterology clinic.
Shazi L; Abbas Z
J Coll Physicians Surg Pak; 2006 Feb; 16(2):104-7. PubMed ID: 16499801
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulins.
Webster AD
BMJ; 1991 Aug; 303(6799):375-6. PubMed ID: 1912799
[No Abstract] [Full Text] [Related]
26. Double trouble: coinfection with HIV and hepatitis C.
Bundow D; Turin C
STEP Perspect; 1999; 99(1):16-7, 20. PubMed ID: 11367157
[TBL] [Abstract][Full Text] [Related]
27. [Should hepatitis C be screened? Risk factors of transmission of hepatitis C virus].
Zarski JP; Leroy V
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S4-10. PubMed ID: 9161509
[No Abstract] [Full Text] [Related]
28. [Hepatitis C and pregnancy: is it necessary to screen for the risk of vertical transmission?].
Soulié JC
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(6):631-4. PubMed ID: 8263293
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis C--the forgotten epidemic].
Meyer R
Dtsch Med Wochenschr; 2006 Oct; Suppl 1():68. PubMed ID: 17598256
[No Abstract] [Full Text] [Related]
30. [Hepatitis C: risk factors and value of screening].
Musset L; Pham BN
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S121-9. PubMed ID: 9161523
[No Abstract] [Full Text] [Related]
31. Infectious risk of plasma donations: relationship to safety of intravenous immune globulins.
Dodd RY
Clin Exp Immunol; 1996 May; 104 Suppl 1():31-4. PubMed ID: 8625541
[TBL] [Abstract][Full Text] [Related]
32. Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005.
Writing Committee of the Consensus Panel
Dig Liver Dis; 2006 Jul; 38(7):445-51. PubMed ID: 16735144
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis C: risk factors].
Vargas Vorácková F
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S9-10. PubMed ID: 12712843
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C: who is at risk and how do we identify them?
Goldberg D; Anderson E
J Viral Hepat; 2004 Sep; 11 Suppl 1():12-8. PubMed ID: 15357858
[TBL] [Abstract][Full Text] [Related]
36. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
37. [Factors related to screening of hepatitis C virus in general medicine].
Rotily M; Loubière S; Prudhomme J; Portal I; Tran A; Hofliger P; Valla D; Moatti JP
Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C and intravenous immunoglobulin. April 29-30, 1995, Orlando, Florida. Papers from the symposium.
Clin Ther; 1996; 18 Suppl B():1-139. PubMed ID: 9081773
[No Abstract] [Full Text] [Related]
39. Safety of intravenous immunoglobulin with regard to hepatitis C virus.
Yu MW; Mason BL; Guo ZP; Tankersley DL
Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443
[No Abstract] [Full Text] [Related]
40. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.
Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD
Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
